Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects

Trial Profile

Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects

Discontinued
Phase of Trial: Phase I

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs UV 4
  • Indications Viral infections
  • Focus Adverse reactions
  • Sponsors Emergent BioSolutions
  • Most Recent Events

    • 21 Jun 2017 Status changed from suspended to discontinued.
    • 22 Feb 2017 Status changed from recruiting to suspended due to pending SMC review and recommendation
    • 10 Jan 2017 Planned End Date changed from 1 Jul 2017 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top